Home  >> Transactions>> Harvard Bioscience acquires AHN Biotechnologie

Harvard Bioscience acquires AHN Biotechnologie

Harvard Bioscience, Inc. (Nasdaq: HBIO), Holliston, MA, a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, has acquired AHN Biotechnologie GmbH (“AHN”). Based in Nordhausen, Germany, AHN is a manufacturer of plastic consumable laboratory products including pipette tips.  This acquisition is complementary to Harvard’s Biochrom product line of molecular biology instruments. EC Mergers & Acquisitions acted as exclusive financial advisor to Harvard Bioscience on this transaction.

Others

Entegris has sold ECP to InnovaFonds      Learn More >>
Wagner SprayTech has acquired HomeRight      Learn More >>
Leatherman has sold Ledlenser to Afinum      Learn More >>
4D Technology has been sold to Nanometrics      Learn More >>
MakeLeaps, Inc. has been sold to Ricoh Company, Ltd.      Learn More >>
Halma has acquired LAN Control Systems      Learn More >>
Xylem has sold Sensus Precision Die Casting (Yangzhou) to SORL Auto Parts      Learn More >>
Randstad has sold Locum Medical Group to Health Carousel      Learn More >>
EMX Industries has been sold to Watervale      Learn More >>
Steel Partners has acquired PST Group      Learn More >>
Galileo TP has been sold to Burke Porter Group      Learn More >>
Entegris Has Acquired Flex Concepts, Inc.      Learn More >>